Superficial Retinal Intercapillary Oxygen Diffusion and Perfusion Deficit Alterations in Patients With Coronary Artery Disease

冠状动脉疾病患者视网膜浅层毛细血管间氧扩散和灌注不足的改变

阅读:1

Abstract

PURPOSE: Retinal imaging may offer a non-invasive method to detect coronary artery disease (CAD). Geometric perfusion deficits (GPDs), defined as intercapillary areas beyond 30 µm from the nearest vessel, were analyzed for their CAD association and topographical patterns. METHODS: Patients undergoing coronary angiography and healthy controls (mean ages: non-CAD, 58 ± 9 years; CAD, 61 ± 9 years) were assessed. Fovea-centered 6 × 6-mm optical coherence tomography angiography (OCTA) images were acquired, and the superficial capillary plexus was analyzed. GPD density, count, ischemic extent (IE), and top 10 GPD areas (MT10) were extracted. The Gensini score (GS) quantified CAD severity. Multivariate mixed-effects models were calculated for statistical analysis. RESULTS: This study analyzed 237 patients (382 eyes), 141 (225 eyes) with CAD. Significant associations with the GS were found across all metrics after adjustments (density coefficient = 0.050, P = 0.001; IE coefficient = 0.002, P = 0.005; MT10 coefficient = 0.066, P = 0.005; count coefficient = 0.015, P = 0.003). The most profound changes were observed in the parafovea. Significant group differences were found between the non-CAD and moderate CAD groups, as well as between the non-CAD and severe CAD groups in the total image and the parafovea, temporal, and nasal outer segments. Moderate and severe CAD did not display significant differences. GPD metrics showed higher predictive abilities than conventional OCTA metrics. CONCLUSIONS: Four GPD metrics were significantly associated with CAD, with the parafoveal area showing the highest significance and consistency. GPDs differed significantly between CAD and non-CAD patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。